Back to top

Commit To Buy Summit Therapeutics At $18, Earn 30.8% Annualized Using Options

Investors considering a purchase of Summit Therapeutics Inc (SMMT) stock, but cautious about paying the going market price of $26.36/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2026 put at the $18 strike, which has a bid at the time of this writing of $2.55..

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Summit Therapeutics PLC (SMMT)